Urticaria & Chronic Hives: How VA Rates Skin Allergies Under DC 7825

The VA rates urticaria under Diagnostic Code 7825 in 38 CFR 4.118. The rating schedule defines three specific percentage tiers: a 60% rating is assigned for attacks that are debilitating and occur daily, or that require continuous treatment with systemic immunosuppressive therapy; a 30% rating applies to attacks occurring at least four times per year, or attacks requiring systemic immunosuppressive therapy; and a 10% rating is granted for attacks controlled by continuous or intermittent antihistamines or other medications.

The critical boundary for higher ratings under DC 7825 centers on the term debilitating and the requirement for systemic therapy. A debilitating attack involves severe, diffuse wheals accompanied by intense pruritus, painful burning, or angioedema (swelling of deeper dermis, lips, eyelids, or throat) that prevents normal daily physical or occupational tasks. Veterans managed exclusively with over-the-counter or prescription oral antihistamines generally receive a 10% evaluation, whereas those requiring biologic agents like omalizumab or courses of oral prednisone qualify for 30% or 60%.

Chronic urticaria frequently stems from immune dysregulation triggered by environmental toxic exposures during military service. Persian Gulf War veterans with unexplained chronic skin symptoms may establish service connection under 38 CFR 3.317 as a medically unexplained chronic multisymptom illness (MUCMI). Similarly, veterans exposed to airborne burn pit particulate matter, chemical agents, or heavy industrial fuels can establish service connection based on direct deployment toxic exposure.

Urticaria frequently coexists with other service-connected atopic and respiratory disorders. Common secondary connections include allergic rhinitis, asthma, and chronic sinusitis linked through shared systemic inflammatory pathways. In addition, chronic urticaria often causes severe nocturnal sleep disturbance, leading to secondary insomnia or depression that can be independently rated under 38 CFR 3.310.

Evidentiary proof is vital because urticaria is an episodic condition that may not present with active hives on the day of a C&P exam. Veterans should maintain a contemporaneous symptom log detailing the date, duration, and severity of each outbreak. Submitting dated color photographs of acute wheals, clinical notes from an allergist or immunologist, emergency room visit summaries for acute angioedema episodes, and continuous pharmacy records provides adjudicators with objective substantiation of daily or recurrent debilitating attacks.